Updated Date: Thu, 24 Sep 2020 00:00:00 EDT

Updated Date: Thu, 24 Sep 2020 00:00:00 EDT

Updated Date: Thu, 24 Sep 2020 00:00:00 EDT

Updated Date: Thu, 24 Sep 2020 00:00:00 EDT

Updated Date: Thu, 24 Sep 2020 00:00:00 EDT

NHS Confederation director responds to latest figures

US Food and Drug Administration broadens investigation into serious adverse event

Fast track designation is based on promising phase Ib results

Diagnostics: Recovery and Renewal report identifies a number of key actions

Researchers have developed a new compound for treating cancer. It destroys a protein that triggers its development.